첫 페이지 › 美股新闻 › 본문

再鼎医药：瑞普替尼用于治疗ROS1阳性非小细胞肺癌患者获国家批准

疯笑缸录发表于 2024-5-13 09:44:07

1172 0 0

　　南方财经5月13日电，再鼎医药港交所公告，中国国家药品监督管理局批准瑞普替尼用于治疗ROS1阳性非小细胞肺癌患者。

CandyLake.com is an information publishing platform and only provides information storage space services.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.

Down

Favorite

Report

转播